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Menin encoded by the multiple endocrine neoplasia type 1
(MEN1) gene is associated with chromatin and the
nuclear matrix and exerts multiple biological functions
including regulation of cell proliferation and adhesion.
Men1 mutations increase the likelihood of lung cancer
development in mice. Menin expression is reduced in
certain human non-small cell lung cancer cells, and
reduction of menin is closely correlated with increased
lung cancer metastasis to lymph nodes. However, it is
poorly understood whether menin affects migration of
lung cancer cells. In this study, we show that menin-
regulated A549 lung cancer cell migration, which was
mediated by growth factor pleiotrophin (PTN) and its cell
surface receptor, protein tyrosine phosphatase beta/zeta
(RPTP b/f). Ectopic menin expression signiﬁcantly
repressed PTN transcription, but indirectly inhibited
RPTP b/f expression through repressing PTN expression.
Further studies revealed that menin-regulated cell migra-
tion through PTN/RPTP b/f, in conjunction with integrin
avb3, focal adhesion kinase, phosphatidylinositol 3-kinase
and phosphorylated extracellular signal regulated kinase 1/2.
These ﬁndings provide mechanistic insights into the
molecular basis for menin/PTN-mediated regulation of
A549 lung cancer cell migration.
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Introduction
Menin encoded by the multiple endocrine neoplasia type 1
(MEN1) gene is a nuclear protein, which is mutated in
patients with an inherited tumor syndrome, MEN1
(Chandrasekharappa et al., 1997). In endocrine tumors
with a germline mutation in one of the MEN1 alleles, the
remaining wild-type MEN1 allele is often inactivated
because of a somatic mutation (loss of heterozygocity),
indicating MEN1 as a bona ﬁde tumor suppressor
gene in endocrine tumors (Lemos and Thakker, 2008).
As menin does not show an obvious homology to any
known protein motifs, it has been challenging to
elucidate how menin acts as a tumor suppressor.
Recently, multiple lines of evidence suggest that
menin is associated with chromatin and nuclear matrix
and exerts multiple biological functions including
regulation of cell proliferation, apoptosis and DNA
repair (Gao et al., 2008). These diverse menin functions
may be largely attributed to the crucial role of menin as
a scaffold protein, which can alter histone tail modiﬁca-
tions and epigenetic status of its target genes to control
their transcription (Wu and Hua, 2008). For instance,
menin represses proliferation of pancreatic islet cells and
mouse embryonic ﬁbroblasts (MEFs) partially through
upregulating transcription of p18
Ink4c (p18) and p27
Kip1
(p27), potent inhibitors of cyclin-dependent kinases
(Schnepp et al., 2006). In this regard, menin interacts
with mixed lineage leukemia proteins (Karnik et al.,
2005; Milne et al., 2005), histone H3 methyltrans-
ferases that catalyze histone H3 lysine 4 methylation
(H3K4me3) with their highly conserved SET domain
(Milne et al., 2002). Menin and mixed lineage leukemia
bind the p18 and p27 gene loci, enhancing H3K4me3 at
these loci, to promote their transcription in endocrine
cells, leading to repression of cell proliferation (Karnik
et al., 2005; Milne et al., 2005).
Nonetheless, it is still poorly understood whether menin
inﬂuences development of non-endocrine tumors, such as
lung cancer. Lung carcinoids occur sporadically and are
also detectable infrequently in patients with MEN1
syndrome (Debelenko et al., 1997, 2000; Petzmann et al.,
2001). Non-small cell lung cancers develop in both Men1
þ/
  and p18
 / ;Men1
þ/  mice, but with a much higher
penetrance in mice with the latter genotype (Pei et al.,
2007). Further study indicated that p18
 /  or Men1
þ/ 
increased pRb phosphorylation at cyclin-dependent kinase
4/6 site Ser
608, and more obviously, increased pRb was
detected in tumor cells from p18
 / ;Men1
þ/  mice (Pei
et al., 2007). These observations suggest a role for menin in
suppressing lung carcinogenesis through regulating cell
proliferation. Consistent with this notion, we recently
found that menin inhibits proliferation of several human
lung cancer cell lines and growth of lung cancer xenograft
(Gao et al., 2009). Consistent with a role of menin in
suppressing development of lung cancer, in 23% of
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www.nature.com/oncprimary human lung adenocarcinomas, menin expression
is signiﬁcantly reduced. Moreover, a reduction in menin
expression is also closely correlated with lymph node
metastasis of the cancer (Gao et al., 2009). As cancer
metastasis involves cell migration and invasion, these
ﬁndings raise the possibility that menin may affect cell
migration.
Our previous work suggests that menin-mediated
suppression of lung cancer is partly through polycomb
gene (PcG)-dependent repression of pleiotrophin (PTN)
expression. PTN is a heparin-binding growth factor that
is highly expressed in certain solid cancers, such as in
breast and lung cancers (Jager et al., 2002; Perez-Pinera
et al., 2007). PTN activates its cell surface receptors,
regulating multiple functions including cell adhesion,
cell migration, cell proliferation and cytoskeletal stabi-
lity (Lu et al., 2005; Pariser et al., 2005; Duces et al.,
2008). These studies raise the possibility that down-
regulated menin expression facilitates the development
of lung cancer not only by repressing lung cancer cell
proliferation, but also by altering lung cancer cell
migration and metastasis. However, the precise mecha-
nisms whereby menin regulates cell migration are not
well understood. We have previously shown that menin
interacts with a scaffold protein, IQ motif containing
GTPase activating protein 1, which links the cyto-
skeleton to cell adhesion and migration in endocrine
cells (Yan et al., 2009). However, it remains poorly
understood as to how menin inﬂuences migration of
non-endocrine tumors, such as lung cancer cells. In this
study, we show that menin regulates A549 lung cancer
cell migration through downregulating expression of
PTN and its cell surface receptor, protein tyrosine
phosphatase beta/zeta (RPTP b/z) (Perez-Pinera et al.,
2007). PTN-RPTP b/z expression and activation of focal
adhesion kinase (FAK) and phosphoinositide 3-kinase
(PI3K) were repressed by menin, and menin-repressed
cell migration involved inhibition of PI3K-extracellular
signal regulated kinase (ERK)1/2 signaling, which is
crucial for cell migration. Together, these results suggest
a novel menin–PTN pathway that controls cell migra-
tion in A549 cells.
Results
Menin inhibits cell migration and represses PTN/RPTP
b/z expression
Previously, we showed that menin expression was
reduced in lung adenocarcinomas, and menin reduction
was highly correlated with increased lymph node
metastasis (Gao et al., 2009). As cancer metastasis
usually involves enhanced cell migration, we sought to
determine whether one of the functions of menin is
involved in controlling cell migration. To this end, we
performed a modiﬁed transwell chamber assay to
evaluate the effect of loss of menin on migration of
Men1
þ/þ and Men1
 /  MEFs. The results indicate that
Men1 ablation signiﬁcantly increased cell migration
(Figure 1a, Po0.05; Supplementary Figure 1a). Next,
we examined whether MEN1 knockdown using short
hairpin RNAs (shRNAs) affects migration of A549 lung
adenocarcinoma cells. Control vector and three distinct
shRNAs that speciﬁcally target human MEN1 were
stably transfected into A549 cells. The resulting cells
were analyzed for knockdown of endogenous MEN1
using both quantitative reverse transcriptase–PCR and
western blotting. MEN1 shRNAs 2–3 substantially
reduced expression of MEN1 mRNA and protein, but
shRNA1 failed to knockdown MEN1 expression
(Figure 1b; Supplementary Figure 1b). Interestingly,
correlated with the levels of MEN1 knockdown by
shRNAs, shRNA 2–3 signiﬁcantly increased A549 cell
migration (Po0.05, respectively), but shRNA1 that
was unable to reduce MEN1 expression failed to do so
(Figure 1c). Together, these results suggest that menin
normally restricts cell migration.
Our previous work has shown that menin suppresses
lung cancer cell proliferation partly through epigenetically
repressing transcription of growth factor PTN (Gao et al.,
2009). PTN is highly expressed in certain solid cancers
(Jager et al., 2002; Perez-Pinera et al., 2007), binds to cell
surface receptors, such as RPTP b/z, and has a crucial role
in cell proliferation, adhesion and migration (Lu et al.,
2005; Pariser et al., 2005; Duces et al., 2008). To examine
whether menin represses lung cancer cell migration partly
through affecting RPTP b/z expression, we evaluated
the effect of loss of menin on RPTP b/z expression in
Men1
þ/þ and Men1
 /  MEFs. Men1 excision (Supple-
mentary Figure 1c) increased mRNA expression of
RPTP b/z (6.5-fold), as detected by quantitative reverse
transcriptase–PCR (Figure 1d) and the downregulated
PTN mRNA expression (eightfold) by menin has been
reported early (Gao et al., 2009). Similar results were also
obtained by detection of PTN and RPTP b/z using regular
reverse transcriptase–PCR (Supplementary Figure 1d).
Increased PTN and RPTP b/z protein levels were detected
in asynchronous Men1 null MEFs, as compared with the
Men1-expressing cells, using western blotting (Figure 1e).
We further determined PTN and RPTP b/z expression
in the Men1
þ/þ and Men1
 /  MEFs in an exponential
growth phase, using immunoﬂuorescence staining. As
illustrated in Supplementary Figure 2, the Men1-null cells
failed to show menin staining (Supplementary Figures 2b
and j), but showed an obvious cytoplasmic staining for
PTN and RPTP b/z (Supplementary Figures 2c and k).
Conversely, menin-expressing MEFs showed a clear
staining for nuclear menin (Supplementary Figures 2f
and n), but a reduction of PTN and RPTP b/z staining
(Supplementary Figures 2g and o). Together, these results
indicate a pivotal role for menin in downregulating both
PTN and its receptor, RPTP b/z expression. To further
conﬁrm these results, we generated three independent pairs
of MEFs to analyze the intrinsic biological effect of menin
on cell phenotype and target gene expression. Similar
results from one of the three pairs of MEFs were presented
in Supplementary Figures 3a and b.
Menin regulates cell migration partly through PTN
and RPTP b/z signaling
Next, we examined whether menin regulates PTN and
RPTP b/z expression in A549 adenocarcinoma cells.
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OncogeneOur previous work has shown that ectopic menin
expression reduces PTN expression (Gao et al., 2009).
A549 cells were stably transfected with either control
vector or a construct-expressing MEN1 (pMX-menin).
Ectopic menin expression was conﬁrmed by western
blotting, and as expected, menin overexpression reduced
the protein level of RPTP b/z (Figure 2a). Further,
MEN1 knockdown by shRNA also increased the
protein level of RPTP b/z in A549 cells (Supplementary
Figure 4). We also examined the effect of MEN1 point
mutations, A242V and L22R, which were identiﬁed
from inherited MEN1 patients (Pannett and Thakker,
1999) on RPTP b/z expression; we found that A242V
and L22R lost or partially lost the ability to repress
RPTP b/z expression (Figure 2b). Correlated with this
result, both wild-type menin and L22R mutant over-
expression signiﬁcantly reduced A549 cell migration
(Po0.05, respectively), however, A242V was unable to
reduce RPTP b/z expression and did not signiﬁcantly
repress cell migration (Figure 2c). Next, we used an
alternative approach, the scratch wound assay, to
compare the motility of mock versus MEN1-over-
expressed A549 cells. The extent of wound closure in
control cells within 4 days of wounding was much higher
than that in ectopically MEN1-expressed A549 cells
(Figure 2d). The dramatic difference between these two
cells reinforces the notion that menin normally represses
cell migration. Next, another pair of stable menin
overexpressed A549 cell lines was established by using
PLNCX2 retrovirus system, and similar results on the
role of menin in regulating PTN/RPTP b/z expression
and cell migration were shown in Supplementary
Figures 5a and b. In addition, another human non-
small cell lung cancer cell line NCI-H157 was used to
conﬁrm the above results. It is noteworthy that ectopic
menin expression not only inhibited PTN/RPTP b/z
expression, but also repressed NCI-H157 cell migration
(Supplementary Figures 5c and d). We further tested
whether PTN/RPTP b/z is required for menin-repressed
A549 cell migration. Three distinct RPTP b/z shRNAs
were transfected into A549 cells, and RPTP b/z
shRNA3 reduced the RPTP b/z protein level effectively
(Figure 2e). It is noteworthy that RPTP b/z knockdown
by shRNA3 reduced migration of A549 cells (Figure 2f).
Furthermore, PTN knockdown effectively reduced
intracellular PTN expression (Figure 2g), concomitant
with reduced A549 cell migration (Figure 2h). Together,
these data indicate that menin inhibits A549 cell
migration at least partly through repressing expression
of PTN and RPTP b/z.
Figure 1 Menin inhibits cell migration and represses PTN/RPTP b/z expression. (a) Men1
þ/þ and Men1
 /  MEFs were added to the
upper-ﬁlter of a transwell, and 24h later, the migrated cells were stained with crystal violet, and cell number was counted under a
microscope. (b) A549 cells were transfected with either vector-expressing shRNAs against Luc or one of the three shRNAs against
MEN1 and selected by G418. The efﬁciency of menin silencing was determined by western blotting. Equal sample loading was
conﬁrmed by Ponceau S staining of the Western blot membrane. (c) The selected A549 cells were added to the upper-ﬁlter, and cell
migration was determined. (d) Increased RPTP b/z mRNA levels in Men1
 /  MEFs were detected by real-time quantitative reverse
transcriptase (qRT)–PCR. The amount of RPTP b/z mRNA was determined by normalizing their mRNA quantity with the control
b-actin mRNA level, and mean values and s.d. were calculated from triplicates of a representative experiment. (e) The efﬁciency of
menin ablation and the effect of Men1 expression on PTN (18kDa) and RPTP b/z (E250kDa) expression were determined by western
blotting, and b-actin was used as a loading control. Equal sample loading was also conﬁrmed by Ponceau S staining of the western blot
membrane. Results in all cases are mean±s.d. percentage change in number of migrating cells vs corresponding untreated cells
(default¼100) and calculated from triplicates of an independent experiment, *Po0.05 vs control.
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OncogeneMenin indirectly regulates RPTP b/z expression
through PTN
As menin represses PTN transcription partly through
PcG-mediated H3K27me3 at the PTN locus (Gao et al.,
2009), we determined if menin also bound to the RPTP
b/z locus using chromatin immunoprecipitation (IP)
assay. However, we failed to detect menin binding to the
RPTP b/z promoter region (data not shown). This may
suggest that menin regulates RPTP b/z transcription
through an indirect mechanism. PTN is a natural ligand
for RPTP b/z, a phosphatase of phosphorylated
tyrosine, and PTN signaling suppresses the phosphatase
activity of RPTP b/z in reducing steady-state of tyrosine
phosphorylation of downstream signaling molecules
(Perez-Pinera et al., 2007). Although it is possible that
menin represses PTN and RPTP b/z separately, we
cannot rule out that PTN positively regulates RPTP
b/z expression.
To further dissect the potential relationship between
menin, PTN and RPTP b/z, we stably transfected A549
cells with PTN shRNA, and the resulting cells were
analyzed for the mRNA and protein levels of PTN and
RPTP b/z. Interestingly, PTN knockdown diminished
the RPTP b/z mRNA and protein levels (Figures 3a
and b). In a complementary approach, we ectopically
expressed menin and/or PTN to determine their effect
on the RPTP b/z mRNA level. As shown in Figure 3c,
menin overexpression reduced both the PTN and RPTP
b/z mRNA levels (lane 2); notably, ectopic PTN
expression abrogated menin-induced reduction of the
Figure 2 Menin inhibits A549 cell migration partly through repressing PTN and RPTP b/z expression. (a) A549 cells were transfected
with MEN1 and selected by puromycin. Expression of menin and downregulated RPTP b/z (E250 and 130kDa) were determined by
western blotting. (b) A549 cells were transfected with an empty vector, wild-type MEN1, point mutation A242V or L22R. Menin and
RPTP b/z expression in the various cell lines above were analyzed by western blotting. (c) The various A549 cell lines were used
to determine cell migration. (d) Menin overexpression inhibited closure of artiﬁcial wounds made in conﬂuent cellular monolayers.
(e) A549 cells were stably transfected with either Luc shRNA or vector expressing one of three distinct RPTP b/z shRNAs, and the
efﬁciency of RPTP b/z knockdown was determined by western blot. (f) A549 cells transfected with RPTP b/z shRNA3 were used to
determine cell migration. (g) A549 cells were transfected with PTN shRNA, and the efﬁciency of PTN knockdown was determined by
western blotting. (h) The cell migration of the above A549 cells was determined by three independent experiments, *Po0.05.
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OncogeneRPTP b/z mRNA level (lane 3). Consistent with this
observation, menin overexpression signiﬁcantly reduced
A549 cell migration (Figure 3d, Po0.05), but PTN
abrogated menin-induced reduction of cell migration
(Figure 3d). Furthermore, addition of recombinant
human PTN to culture medium upregulated the RPTP
b/z protein level, as shown by western blotting
(Figure 3e), as well as A549 cell migration (Figure 3f).
Together, these ﬁndings strongly suggest that PTN
upregulates RPTP b/z expression, whereas menin
represses RPTP b/z expression indirectly through
inhibiting PTN expression.
PTN increases interaction between RPTP b/z
and integrins
Integrin avb3 is important for cell signaling, survival and
migration particularly during angiogenesis and tumor-
igenesis (del Pozo et al., 2004). However, the role of
integrins for the migration of lung cancer cells has not
been analyzed extensively. Integrin avb3 is a potential
receptor for PTN and is required for PTN-induced
endothelial cell migration through RPTP b/z (Mikelis
et al., 2009). Thus, PTN/RPTP b/z signaling may affect
lung cancer cell migration in conjunction with integrins.
Our results indicate that RPTP b/z expression was
stimulated by PTN in A549 cells (Figure 3e). It is
noteworthy that immunoﬂuorescence staining results
indicate that PTN substantially increased expression
of both RPTP b/z and integrin b3 and colocalization
of RPTP b/z and integrin b3 in the A549 cells (Figure 4a).
This result prompted us to analyze whether
av/b3 associates with RPTP b/z. We performed
co-IP from extracts of A549 lung cancer cells and
found that endogenous integrin av and b3 were
co-immunoprecipitated with endogenous RPTP b/z
(Figure 4b). As a control, IgG failed to pull down av
and b3 (Figure 4b). The interaction between av and RPTP
b/z was further conﬁrmed by IP of endogenous RPTP b/z
with av antibody (Figure 4c). In addition, interaction
between av and b3 was also detected in A549 cells
(Figures 4c and d). We further examined the effect of
menin on av and b3 expression in A549 cells and in
Men1
þ/þ and Men1
 /  MEFs. Western blotting revealed
that menin overexpression did not affect expression of
either av or b3 in A549 cells (Supplementary Figure 6a)
and similar results were obtained in Men1 null MEFs
(Supplementary Figure 6b), suggesting that PTN tran-
siently increases the integrin expression and their
colocalization with RPTP b/z. Overall, the results above
indicate that PTN stimulation increases expression of
both RPTP b/z and integrins, as well as their interaction.
Menin inhibits activation of FAK, PI3K and ERK1/2,
which were crucial for cell migration
RPTP b/z is an important regulator in the reciprocal
control of the steady-state tyrosine phosphorylation
levels of b-catenin by tyrosine kinases and phosphatases
(Meng et al., 2000). b-Catenin acts as a key factor in the
E-cadherin-mediated cell–cell adhesion (Nelson and
Nusse, 2004). To elucidate cell signaling underlying
menin/PTN-regulated cell migration, we tested if the
menin-regulated cell migration requires b-catenin signal-
ing. However, no substantial difference in expression of
b-catenin or its Tyr 142 phosphorylation was detected
in both A549 and MEFs (Supplementary Figures 6a
and b), raising the possibility that other key factors link
menin/PTN signaling to cell migration. FAK, a protein
tyrosine kinase that is recruited at an early stage to focal
Figure 3 MEN1 indirectly regulates RPTP b/z expression through PTN in A549 cells. (a, b) A549 cells were transfected with PTN
shRNA, and the resulting cells were processed to determine PTN and RPTP b/z mRNA and protein levels using reverse transcriptase
(RT)–PCR and western blotting, respectively. (c) A549 cells were transfected with either control vector (30mg) or construct expressing
either MEN1 (MEN1 15mgþvector 15mg), or co-transfected with MEN1 and PTN-expressing constructs (MEN1 15mgþPTN 15mg).
The resulting cells were processed to determine menin, PTN and RPTP b/z mRNA levels by RT–PCR. (d) The resulting cells were
monitored for their migration, N¼3, *Po0.05 vs control. (e, f) recombinant human PTN (rhPTN) (100ng/ml) increased RPTP b/z
expression and migration of A549 cells.
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Oncogeneadhesions, mediates many downstream adhesion
responses, including activation of the p85-subunit of
PI3K (Baillat et al., 2008). To examine whether menin
affects FAK, we evaluated the effect of loss of menin on
expression of FAK in Men1
þ/þ and Men1
 /  MEFs.
Men1 excision did not affect the total amount of FAK,
but substantially increased the level of its Tyr 397-
phosphorylated form (Figure 5a). We further deter-
mined the effect of menin on PI3K and ERK1/2, other
downstream effectors of FAK (Baillat et al., 2008),
in the MEFs. The results indicate that Men1 excision
increased expression and consequently, phosphorylation
(Tyr458) of PI3K, as well as ERK1/2 phosphorylation
(Thr202/Tyr204) (Figure 5a). Indeed, similar results
on menin’s role in reducing the phosphorylated forms of
FAK and ERK1/2 were obtained in menin over-
expressed A549 cells (Figure 5b). Consistently, the
menin-null MEFs showed obvious cytoplasmic stain-
ing for pERK1/2, while menin-expressing MEFs
showed much weaker staining for pERK1/2 (Supple-
mentary Figure 6c). Collectively, these results suggest
that FAK signaling may link menin/PTN to cell migra-
tion partly through regulating PI3K and ERK1/2
phosphorylation.
Cell morphology and migration are known to be
regulated by members of the Rho family of small
GTPases, including Rho, Rac1 and Cdc42 (Hall, 1998).
Rac1 and Cdc42 are activated by ligation of integrins,
whereas Rho activation relies on either integrins,
syndecan-4 or additional cell-surface receptors (Hood
and Cheresh, 2002). Hence, we further examined if
menin-regulated PTN expression controls cell migration
partly through Rho family signaling. Ectopic menin
expression did not alter the amount of either activated
forms (GTP-bound) or the total amount of Rho, Rac1
and Cdc42 in A549 cells (Figure 5c). Similar results were
obtained in Men1-null or Men1-expressing MEFs
(Supplementary Figure 7). Interestingly, the Cdc42-
GTPase and Rac1-GTPase activity were transiently
induced by PTN at 10–30min (Figure 5d), similar to
the induction of RPTP b/z and integrins by PTN
(Figure 4a). As menin inhibited expression of PTN, as
well as phosphorylation of FAK and ERK1/2, but did
not affect Cdc42 and Rac1 activities, it is likely that
menin-mediated repression of PTN leads to relatively
long-lasting repression of the FAK-ERK1/2, but only
transient repression of the Rho family of the GTPases in
regulating cell migration.
Menin inhibits FAK-ERK activation through PTN/RPTP
b/z and partly represses migration through inhibiting
ERK1/2 phosphorylation
It is unclear how menin regulates FAK activation.
We examined whether RPTP b/z interacts with FAK in
A549 cells, but failed to observe interaction between
them using co-IP. It has been reported that integrin–
FAK interaction may serve as a downstream effector of
PTN (Mikelis et al., 2009), and integrin av/b3 directly
interacts with RPTP a or RPTP b/z, which is essential
for integrin b3 activation (von Wichert et al., 2003;
Mikelis et al., 2009). FAK is itself regulated by various
Figure 4 PTN increases interaction of RPTP b/z and integrins. (a) Serum-starved A549 cells were treated with 100ng/ml recombinant
human PTN (rhPTN) and harvested at various time points. RPTP b/z (red), b3 (green) and 4,6-diamidino-2-phenylindole (DAPI)
(blue) were detected by IF, 1600-fold. (b–d) A549 cell lysates were IP for RPTP b/z, av and b3, and immunoprecipitates were analyzed
by western blotting for the presence of RPTP b/z, av, b3.
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Oncogenemechanisms, including tyrosine phosphorylation, serine/
threonine phosphorylation and protein–protein interac-
tions (McLean et al., 2005). Therefore, we tested if
downregulation of FAK phosphorylation is mediated by
menin through downregulating PTN/RPTP b/z expres-
sion. To this end, serum-starved A549 cells were
stimulated by addition of recombinant human PTN
and allowed to progress for various periods of time
before analysis. The results indicate that phosphoryla-
tion of FAK was obviously increased after 15min of
treatment with PTN, reached a peak between 30 and
60min after the treatment, but went down after 120min
(Figure 6a). In contrast, phosphorylation of ERK1/2
was abruptly increased 15min after exposure to PTN,
but rapidly reduced 30min after treatment with PTN
(Figure 6a). Consistently, knockdown of PTN or RPTP
b/z reduced basal level of phosphorylation of FAK and
ERK1/2 (Figure 6b). These results suggest that PTN can
increase phosphorylation (or activation) of both FAK
and ERK1/2; however, as the kinetics of phosphory-
lation of ERK1/2 and FAK is distinct, they might be
activated by the PTN pathway in a distinct manner.
Activated FAK has an essential role for maintenance of
several cell phenotypes, including cell migration through
PI3K/mitogen-activated protein kinase signaling
(McLean et al., 2005). We thus examined if PI3K and
ERK1/2 were involved in menin-regulated cell migra-
tion. A549 cells were treated with LY294002 or U0126,
respectively, inhibitors for PI3K and MEK1/2, respec-
tively. The PI3K inhibitor reduced phosphorylation of
ERK1/2, but not the total amount of ERK1/2 in A549
cells (Supplementary Figure 8), and decreased A549 cell
migration in a dose-dependent manner (Figure 6c).
As expected, the migration of A549 cells treated with the
MEK1/2 inhibitor was also reduced in a dose-dependent
manner (Figure 6c). In addition, we collected six cases
with menin downregulated primary lung adenocarcino-
mas, and found that the levels of RPTP b/z and pERK1/
2 were high, as shown by immunohistochemistry in two
of six cases (Supplementary Figure 9). These results
suggest that menin-regulated PTN-ERK1/2 pathway
could be involved in development of certain lung
adenocarcinoma. Together, our results suggest that
menin inhibits FAK and ERK1/2 phosphorylation
partly through PTN/RPTP b/z expression, and
ERK1/2 activation may have a role for menin-mediated
repression of lung cancer cell migration.
Discussion
Cell migration is a crucial step of cancer metastasis,
a major cause of cancer-related death (Molloy and van ’t
Veer, 2008). Many oncogenes and tumor suppressor
genes are involved in regulating tumor cell migration,
invasion and metastasis (Klein, 2008). For example,
PTEN is well known for its role in regulating tumor
growth, invasion, and metastasis, and it is capable of
restricting growth and survival by antagonizing the
activity of PI3K (Tamura et al., 1999; Chen et al.,
2009a). MEN1, a bona ﬁde tumor suppressor gene in
endocrine tumors, exerts multiple biological functions
including regulation of cell proliferation (Gao et al.,
2008). Until recently, little has been known regarding
the function of menin in controlling cancer cell
migration.
We found that menin expression in tumors, as
compared with the adjacent normal epithelial cells,
was markedly reduced or not detectable in 10 out of
45 adenocarcinoma samples, and reduction of menin
Figure 5 Menin inhibits activation of FAK, PI3K and ERK1/2. (a) The efﬁciency of menin ablation and its effect on upregulation of
pFAK, PI3K (85kDa), pPI3K and pERK1/2 were determined by western blotting. (b) The effect of ectopic menin expression on FAK
(125kDa), pFAK, ERK1/2 (42 and 44kDa) and pERK1/2 in A549 cells were determined using western blotting. (c) PAK1-PBD
agarose and Rhotekin RBD agarose were used to isolate GTP-Cdc42, GTP-Rac1 and GTP-RhoA from whole cell lysates from menin-
overexpressing A549 cells. The Cdc42-GTP, Rac1-GTP and RhoA-GTP were detected using western blotting and normalized by the
total input protein. (d) Serum-starved A549 cells were treated with 100ng/ml recombinant human PTN (rhPTN) and harvested at
various time points. The activation of Cdc42, Rac1 and RhoA were detected by western blotting and normalized by the total input
protein.
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Oncogeneexpression was correlated with an increase in lymph node
metastasis (Gao et al., 2009). Further investigation has
revealed that menin represses migration of lung cancer
cells, at least partly through inhibiting expression of
PTN/RPTP b/z, a growth factor and its cell surface
receptor that are involved in controlling cell proliferation,
migration and apoptosis (Perez-Pinera et al.,2 0 0 7 ) .
However, unlike menin-mediated epigenetic repression
of PTN transcription through H3K27me3, menin re-
presses RPTP b/z expression possibly indirectly through
inhibiting PTN expression. It remains unclear how PTN
normally upregulates expression of its receptor, RPTP b/
z. As PTN has several candidate receptors including
anaplastic lymphoma kinase and integrin avb3 (Stoica
et al., 2002; Mikelis et al., 2009), one possibility is that
PTN activates these receptors and thus indirectly
upregulates expression of RPTP b/z.C o n s i s t e n tw i t h
these scenarios, our previously ﬁnding that menin can
directly and indirectly downregulate at least two crucial
components of the PTN pathway, both PTN and a
downstream receptor, anaplastic lymphoma kinase (Gao
et al., 2009), respectively, highlights the importance of
menin in controlling this signaling pathway.
Integrin signaling is a major pathway in regulating
cell adhesion to extra-cellular matrices. Interaction
between integrins and their substrates regulates various
cellular functions associated with tumor development
and metastatic progression, including cell adhesion,
migration and invasion (Tamura et al., 1999; Chen et al.,
2009b). Integrin-mediated cell adhesion not only initi-
ates signals directly, but also modulates signaling
downstream of growth factor receptors; the integrin-
FAK signaling pathway enables RhoA to activate its
effectors in cell migration (Palazzo et al., 2004). It has
been reported that PTN activates signal transduction
through RPTP b/z or integrin (avb3) and migration of
endothelial cells (Mikelis et al., 2009). In particular,
PTN induces migration of the cells through activating
FAK, PI3K and ERK (Polykratis et al., 2005). Our
results show that RPTP b/z interacted with integrin av
and b3 in A549 cells, and that menin not only inhibits
expression of PTN, but also represses the activation
(phosphorylation) of FAK, PI3K and ERK1/2. The
FAK signaling complex acts to recruit and/or phos-
phorylate a number of signaling proteins and is involved
in cell adhesion and the motile and invasive phenotype
in lung cancer cells (Liu et al., 2008). FAK is
upregulated in non-small cell lung cancers (Carelli
et al., 2006), and ﬁbronectin-mediated activation of
FAK leads to lung cancer metastasis through ERK or
PI3K/Akt pathway (Meng et al., 2009). Furthermore,
inhibition of MEK1/2 using PD98059 also reduced cell
migration and invasion (Meng et al., 2009). In agree-
ment with these observations, our results indicate that
A549 lung cancer cell migration was signiﬁcantly
reduced by PI3K and MEK1/2 inhibitors, respectively
Figure 6 Menin regulates FAK and ERK1/2 activation through PTN/RPTP b/z and represses cell migration partly through ERK1/2.
(a) Serum-starved A549 cells were treated with 100ng/ml recombinant human PTN (rhPTN) and harvested at various time points. The
activation of FAK and ERK1/2 were determined with western blotting. (b) A549 cells were transfected with PTN or RPTP b/z shRNA,
pFAK and pERK1/2 were examined with western blotting. (c) Migration of A549 cells treated with LY294002 or U0126 were
signiﬁcantly reduced in a dose-dependent manner. N¼3, *Po0.05. (d) A model for regulation of cell migration by menin through
growth factor PTN/RPTP b/z.
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Oncogene(Figure 6c). Hence, menin may inhibit A549 cell
migration partly by repressing PTN and its receptor
RPTP b/z expression, and ectopic menin expression
reduced the active and phosphorylated forms of FAK,
PI3K and ERK1/2, but did not affect b-catenin
expression and nuclear localization. However, the
precise mechanism for downregulation of FAK, PI3K
and ERK1/2 by menin remains to be analyzed.
Collectively, our ﬁndings unravel a previously un-
recognized pathway in controlling A549 lung cancer
cell migration, that is, the menin-PTN pathway. This
mechanism is quite distinct from menin-regulated inter-
cellular adhesion of pancreatic b-cells, in which menin
interacts with the IQ motif containing GTPase activat-
ing protein 1, a scaffold protein, and reduces GTP-Rac1
interaction with IQ motif containing GTPase activating
protein 1, but increases E-cadherin/b-catenin interaction
with IQ motif containing GTPase activating protein 1
(Yan et al., 2009). Consistent with these ﬁndings, PTN is
abundantly expressed in fetal lung epithelial cells of rats
and enhances cell proliferation (Weng et al., 2009).
Although PTN increases b-catenin phosphorylation and
nuclear translocation in lung epithelial cells (Weng
et al., 2009), we failed to observe an effect of PTN on
b-catenin phosphorylation in A549 lung cancer cells
(Supplementary Figure 6a). It is likely that the cancer
cells respond distinctly to PTN stimulation. These
ﬁndings suggest multiple roles for menin in regulating
adhesion, migration and signal transduction in distinct
types of cells.
Our results have provided new insight into menin-
regulated PTN/RPTP b/z signal transduction in con-
trolling A549 lung cancer cell migration. These studies
have unraveled the crucial mechanisms whereby menin
represses migration at least partly through suppressing
the PTN/RPTP b/z in repressing lung cancer migration.
As menin actively represses PTN-induced lung cancer
cell migration and loss of menin expression is closely
correlated with enhanced lung cancer metastasis to
lymph nodes, the menin-PTN pathway in regulating cell
migration and metastasis may serve as a target for
therapy against lung adenocarcinoma.
Materials and methods
Cell culture and gene transfection
MEF cell line generation and culture were previously described
(Schnepp et al., 2006). A549 and NCI-H157 cell culture and
polyethylenimine-mediated plasmid transfection were per-
formed, as previously described (Gao et al., 2009). A549 cells
were treated with or without recombinant human PTN (R&D,
Minneapolis, MN, USA), PI3K inhibitor (LY294002) (Cell
Signaling, Danvers, MA, USA), and MEK1/2 inhibitor
(U0126) (Cell Signaling).
Western blotting
The cells were lysed in radioimmunoprecipitation assay buffer
(Jin et al., 2007), and the extracted proteins were resolved by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
before transfer onto PVDF membrane, and each of the
antibodies was incubated against one of the following proteins:
menin (Bethyl, Montgomery, AL, USA), PTN (Abnova,
Walnut, CA, USA), RPTP b/z (BD, San Jose, CA, USA),
FAK (Santa Cruz, Santa Cruz, CA, USA), Tyr397 phospho-
FAK (Invitrogen, Carlsbad, CA, USA), ERK1/2 (Cell
Signaling), Thr202/Tyr204 phospho-ERK1/2 (Cell Signaling),
integrin av (Millipore, Billerica, MA, USA), integrin b3 (Santa
Cruz), PI3K p85 (Cell Signaling), Tyr458 phospho-PI3K (Cell
Signaling), b-catenin (Cell Signaling), Tyr142 phospho-b-
catenin (Abcam, Cambridge, MA, USA) and b-actin (Santa
Cruz). Membranes were further washed and incubated with an
anti-rabbit or
anti-mouse secondary antibody (Pierce, Rockford, IL, USA).
Detection of immunoreactive bands was performed using an
ECL detection kit (Pierce), according to the manufacturer’s
instructions. Equal protein loading was indicated by
Ponceau-S staining of blotted membranes.
IP assay
IP assays were performed essentially, as previously described
(Yan et al., 2009). Brieﬂy, the harvested cells were lysed and
incubated with a primary antibody or normal rabbit IgG
(Millipore). Protein A or protein G-agarose beads (Santa
Cruz) were added. Bound proteins were collected by centri-
fugation, washed and analyzed by western blotting.
Cell migration assay and scratch wounding assay
Migration assays were performed, as previously described
(Mikelis et al., 2009), in 24-well transwell plates (Millipore)
using uncoated polycarbonate membranes with 8mm pores.
Serum-starved cells were harvested and re-suspended at
a concentration of 1 10
4 cells per 0.2ml in serum-free
medium containing 10% bovine serum albumin, and added
to the upper chamber. At 24h after incubation, non-migrated
cells were scraped off the upper side of the ﬁlter, and
ﬁlters were stained with 0.1% crystal violet. The number of
migrated cells on the reverse side of the membrane was
quantiﬁed by average cell counts from six random ﬁelds
in each well, under a microscope at  100 magniﬁcations
(Supplementary Figure 1a). Each condition was assayed
in triplicate wells, and the resulting data were subjected to
statistical analysis using the Student’s t-test. For scratch
wound assay, subconﬂuent cells were scraped using sterilizing
10ml pipette tips, washed with phosphate-buffered saline and
cultured in normal medium. The cells were observed under a
Nikon Eclipse TE 300 inverted microscope (Nikon Corpora-
tion, Tokyo, Japan), and images were captured daily.
Statistical analysis
Values were presented as the mean±s.d. Statistical compa-
risons between groups were conducted using the Student’s
t-test, and Po0.05 was considered statistically signiﬁcant.
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